Search

STAAR Surgical Co

Atidarymo kaina

SektoriusSveikatos priežiūra

23.08 -0.22

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

22.87

Max

23.51

Pagrindiniai rodikliai

By Trading Economics

Pajamos

2.9M

8.1M

Pardavimai

13K

94M

P/E

Sektoriaus vid.

344.143

57.371

Pelnas, tenkantis vienai akcijai

0.18

Pelno marža

8.615

Darbuotojai

921

EBITDA

3M

13M

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+28.22% upside

Dividendai

By Acuity

Kitas uždarbis

2026-11-03

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-43M

1.2B

Ankstesnė atidarymo kaina

23.3

Ankstesnė uždarymo kaina

23.08

Naujienos nuotaikos

By Acuity

50%

50%

147 / 340 reitingas Healthcare

STAAR Surgical Co Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-08-20 20:02; UTC

Shares of STAAR Surgical Co are lower today, following Walmart's disappointing earnings report and broader market weakness. The stock remains below its 20-day moving average.

2026-08-19 20:02; UTC

News

STAAR Surgical Co's second-quarter revenue of $93.54 million exceeded estimates, driven by increased EVO Plus adoption in China. Shares are higher, despite pulling back earlier.

2026-08-18 19:36; UTC

Shares of STAAR Surgical Co. are trading higher today, recovering from an earlier dip and positioned above their 20-day moving average.

2026-08-17 22:52; UTC

STAAR Surgical Co. shares remained roughly flat in after-market trading, showing minimal change since Monday's close amid routine trading behavior.

2026-08-14 23:46; UTC

STAAR Surgical Co. shares declined after-market, reflecting broader market sentiment amid an unexpected drop in U.S. retail sales for July.

2026-08-13 20:02; UTC

Social Media
News

STAAR Surgical shares are lower after UBS cut its price target to $19.00, despite reporting strong second-quarter sales of $93.5 million.

2026-08-12 23:56; UTC

Social Media
News

STAAR Surgical shares are lower in after-market hours following an EPS miss, despite reporting second-quarter net sales of $93.5 million, a 111% increase.

2026-08-11 20:01; UTC

News

STAAR Surgical Co shares are lower today, reflecting broader market declines amid rising oil prices and inflation concerns ahead of U.S. inflation reports.

2026-08-10 20:02; UTC

Social Media
News

Broadwood has acquired over 1 million additional shares of STAAR Surgical, reflecting its long-term strategy, as the stock trades higher since Friday's close.

2026-08-07 22:56; UTC

Shares of STAAR Surgical Co. are trading higher in after-market hours, continuing a positive trend amid a supportive market backdrop following a decline in the unemployment rate.

2026-08-06 20:03; UTC

STAAR Surgical Co. shares are higher today, reflecting gains since Wednesday's close, though the stock remains below its 20-day moving average.

2026-08-05 20:02; UTC

STAAR Surgical shares are lower today, continuing a decline since Tuesday's close amid broader market volatility and external factors not directly impacting the company.

2026-08-04 19:51; UTC

STAAR Surgical Co shares are lower as Health Care Supplies sub-sector performance weighs on the stock. No specific news was identified for the decline.

2026-08-03 20:03; UTC

No specific news for STAAR Surgical as shares trade near unchanged. The broader market sees gains amid strong buying interest in technology stocks.

2026-07-31 19:52; UTC

STAAR Surgical Co shares are lower amid weakness in the Health Care Supplies sub-sector. The stock has seen modest declines since Thursday's close.

2026-07-30 19:29; UTC

STAAR Surgical Co. shares are lower today, reflecting a decline since Wednesday amid broader market volatility and rising Treasury yields.

2026-07-29 22:11; UTC

STAAR Surgical Co shares are lower in after-market hours amid significant declines in the Health Care Supplies sub-sector, with no specific news identified.

2026-07-28 18:56; UTC

News

STAAR Surgical Co shares declined after UBS initiated coverage with a Sell rating and set a price target of $20.00, closing at $22.95.

2026-07-27 19:07; UTC

STAAR Surgical Co. shares are trading lower, continuing a recent downward trend amid broader market sentiment affected by declining crude oil prices.

2026-07-22 18:11; UTC

News

Wedbush reiterated its OUTPERFORM rating on STAAR Surgical, maintaining a $40 price target, contributing to shares trading higher today.

2026-07-21 16:56; UTC

Social Media

STAAR Surgical preannounces second-quarter revenue over $90 million, up from $44.3 million last year, as shares gain amid market volatility.

2026-07-20 20:01; UTC

News

STAAR Surgical shares are lower amid investor concerns over sustainability despite projected Q2 sales exceeding $90 million and strong growth in China and the Americas.

Akcijų palyginimas

Kainos pokytis

STAAR Surgical Co Prognozė

Kainos tikslas

By TipRanks

28.22% į viršų

12 mėnesių prognozė

Vidutinis 29.67 USD  28.22%

Aukščiausias 40 USD

Žemiausias 20 USD

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines STAAR Surgical Co kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

8 ratings

2

Pirkti

5

Laikyti

1

Parduoti

Rinkos nuotaikos

By Acuity

147 / 340 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę STAAR Surgical Co

STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
help-icon Live chat